Amphastar Pharmaceuticals: Q4 Earnings Insights

Amphastar Pharmaceuticals AMPH reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Amphastar Pharmaceuticals beat estimated earnings by 13.51%, reporting an EPS of $0.42 versus an estimate of $0.37.

Revenue was up $24.97 million from the same period last year.

Last quarter the company beat on EPS by $0.22 which was followed by a 4.06% increase in the share price the next day.

Here's a look at Amphastar Pharmaceuticals's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	0.24	0.21	0.18	0.14
EPS Actual	0.46	0.21	0.27	0.16
Revenue Estimate	103.24M	101.78M	97.26M	88.94M
Revenue Actual	112.20M	101.66M	103.02M	95.92M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar